For patients with skin of color and atopic dermatitis (AD), lebrikizumab is efficacious and safe, according to a study ...

A 28-year-old woman was admitted to the hospital because of severe hypoxemia and right heart failure that had been caused by rapidly progressive pulmonary hypertension. A diagnosis was made.